Prednisone Market Analysis

  • Report ID: 5384
  • Published Date: Nov 26, 2025
  • Report Format: PDF, PPT

Prednisone Market Segmentation:

Disease Segment Analysis

The skin allergies segment is projected to hold 40% share of the global prednisone market by 2035. There has been a growing prevalence of acne all across the globe. A lot of people have acne, and it affects about 8% of the global population, according to research estimates. Additionally, cases of acne are highly seen among teenagers. This prevalent skin condition, which affects over 84% of teenagers, is characterized by clogged pores (whiteheads and blackheads), uncomfortable pimples, and occasionally hard, deep lumps on the face, neck, shoulders, chest, back, and upper arms. Hence, with the growing population of teenagers, the segment is set to have significant growth over the forecast period.

Application Segment Analysis

Prednisone market from the hospital segment is poised to generate the highest revenue share of about 50% over the coming years. This could be owing to the growing investment made in the healthcare sector. Additionally, the number of patients getting admitted to hospitals is also surging. Hospitalized individuals who have a wide range of serious illnesses, such as those with neurological, pulmonary, and cardiovascular diseases, might benefit from steroids. Hospitals provide care for a wide variety of illnesses through dermatology medical devices. Hospitalist physicians typically have a focus on internal medicine, pediatrics, or family practice. They have the resources to handle complex medical problems as well as the knowledge to assist with routine ones. Moreover, there has been an increase in advancement in hospitals and a wide array of medicines are available here.

Our in-depth analysis of the global prednisone market includes the following segments:

         Disease

  • Rheumatology Indications

  • Skin Allergies

  • Endocrinology

  • Gastroenterology

  • Acute Respiratory Disease

          Application

  • Hospital

  • Clinic

  • Recovery Center

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of prednisone is assessed at USD 6.91 billion.

The global prednisone market size was valued at around USD 6.6 billion in 2025 and is projected to grow at a CAGR of more than 5.3%, reaching USD 11.06 billion revenue by 2035.

North America is estimated to secure a 35% revenue share in the prednisone market by 2035, fostered by the rising prevalence of asthma in the region.

Key players in the market include Pfizer Inc., Merck & Co., Inc., GSK plc, Sanofi, AstraZeneca, Eli Lilly and Company, AbbVie Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos